The Cooper Companies, Inc. $COO Shares Sold by Kayne Anderson Rudnick Investment Management LLC

Key Points

• Kayne Anderson Rudnick Investment Management LLC reduced its stake in The Cooper Companies by 1.2%, holding 7,985,239 shares after selling 97,641 shares in the first quarter.
• Multiple institutional investors are adjusting their positions in The Cooper Companies, with Mirae Asset Global Investments increasing its stake by 15.1% in the same period.
• Analysts have mixed ratings on Cooper Companies stock, with a consensus average rating of "Moderate Buy" and a target price of $96.73, despite some brokerages lowering their price objectives.

Kayne Anderson Rudnick Investment Management LLC reduced its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,985,239 shares of the medical device company's stock after selling 97,641 shares during the period. Cooper Companies makes up 1.6% of Kayne Anderson Rudnick Investment Management LLC's holdings, making the stock its 10th biggest position. Kayne Anderson Rudnick Investment Management LLC owned 3.99% of Cooper Companies worth $673,555,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock valued at $2,194,000 after acquiring an additional 3,440 shares during the last quarter. DAVENPORT & Co LLC lifted its position in shares of Cooper Companies by 13.4% during the 1st quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after buying an additional 513 shares during the last quarter. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 6.6% in the 1st quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock valued at $1,443,000 after acquiring an additional 1,054 shares during the period. State of Alaska Department of Revenue increased its holdings in shares of Cooper Companies by 3.0% in the 1st quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock valued at $1,972,000 after acquiring an additional 680 shares during the period. Finally, Cetera Investment Advisers increased its stake in Cooper Companies by 1.3% in the 4th quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock valued at $2,211,000 after buying an additional 312 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

COO has been the topic of a number of recent analyst reports. UBS Group raised shares of Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Wells Fargo & Company cut their price objective on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating on the stock in a report on Thursday. Mizuho cut their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 22nd. Finally, Wall Street Zen downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Trading Up 2.7%

NASDAQ COO traded up $1.72 on Friday, hitting $66.30. 1,539,074 shares of the company were exchanged, compared to its average volume of 2,251,349. The company's 50 day moving average price is $72.33 and its 200-day moving average price is $77.68. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The firm has a market capitalization of $13.26 billion, a P/E ratio of 32.63, a price-to-earnings-growth ratio of 1.81 and a beta of 1.00. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a return on equity of 9.88% and a net margin of 10.08%.The business's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.